According to Ha et al. [122], the mean frequency of TET2 mutation was 12.1% and displayed no significantly difference among PV (22.2%), ET (9.7%), PMF (18.2%), and unclassified MPN (0%) (p = 0.314). This evidence concerns the gene TET2 and myeloproliferative disorder.